MedPath

The Use of Social Media Platform to Continuously Support Pregnant Women With Gestational Diabetes Mellitus

Not Applicable
Recruiting
Conditions
Gestational Diabetes
Interventions
Behavioral: Additional GDM management through social media
Behavioral: Usual care
Registration Number
NCT06292871
Lead Sponsor
KK Women's and Children's Hospital
Brief Summary

To assess the efficacy of utilizing a social media platform for dietary and lifestyle management in improving acceptance and blood glucose control in patients with gestational diabetes mellitus (GDM), compared to the control group under usual care. Specifically,

i. To measure the participants' acceptability and satisfaction levels of receiving intervention through the social media platform.

ii. To measure the feasibility of using the social media platform to provide GDM support through participants' engagement levels and feedback questionnaire.

iii. To measure the efficacy of using the social media platform to manage emotional responses in women with GDM.

iv. To measure the efficacy of using the social media platform to optimize glycemic control in women with GDM.

Detailed Description

Engaging pregnant women with GDM in dietary management over the gestation has been challenging. This pilot trial aims to assess the efficacy of utilizing a social media platform for dietary and lifestyle management in improving acceptance and blood glucose control among patients with GDM, compared to a control group receiving usual care. The study will employ a randomized controlled trial design, with GDM patients from KK Women's and Children's Hospital (KKH) randomly assigned to either the usual care (control; n=40) or to additional support via a dedicated social media platform for a period of 1 month, where a moderator will be available to address patients' queries and share relevant educational resources (intervention; n=40). Outcome measures include acceptance, satisfaction, and engagement levels, emotional well-being as well as the percentage achievement of time-in-range glucose readings for GDM patients. The independent t-test will be used to compare the outcome measures between groups. The findings from this study will provide valuable insights into the feasibility and efficacy of incorporating digital platforms into routine dietary counselling practices for improved patient outcomes and enhanced management of GDM.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
80
Inclusion Criteria
  • Diagnosed with GDM as confirmed by the Oral Glucose Tolerance Test during pregnancy
  • Age β‰₯ 21 and ≀ 45 years
  • Attended first (baseline) session of GDM diet counselling session
  • Able to read and comprehend English
  • Have a digital device accessible to social media platform
  • Have SingPass access
  • Able to provide informed consent
Exclusion Criteria
  • With known Type 1 or Type 2 diabetes
  • Have multiple pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention GroupUsual carePregnant women with GDM receiving additional support via social media platform continuously for 1 month, in addition to the usual care management.
Intervention GroupAdditional GDM management through social mediaPregnant women with GDM receiving additional support via social media platform continuously for 1 month, in addition to the usual care management.
Control GroupUsual carePregnant women with GDM under usual care management.
Primary Outcome Measures
NameTimeMethod
Acceptance levelsAt the end of one month from baseline visit

Assessed by a 5-point Likert-type scale, ranging from 1 (completely disagree) to 5 (completely agree). A higher score indicates a higher acceptance level.

Satisfaction levelsAt the end of one month from baseline visit

Assessed by a 5-point Likert-type scale, ranging from 1 (completely disagree) to 5 (completely agree). A higher score indicates a higher satisfaction level.

Secondary Outcome Measures
NameTimeMethod
Engagement levelsAt the end of one month from baseline visit

Assessed by frequency of interactions with the platform moderator and frequency of platform visits among women in the intervention group

Appropriateness levelsAt the end of one month from baseline visit

Assessed by a 5-point Likert-type scale, ranging from 1 (completely disagree) to 5 (completely agree). A higher score indicates a greater appropriateness level.

Blood glucose levelsAt the end of one month from baseline visit

Assessed by finger prick tests, in mmol/L

Feasibility levelsAt the end of one month from baseline visit

Assessed by a 5-point Likert-type scale, ranging from 1 (completely disagree) to 5 (completely agree). A higher score indicates a higher feasibility level.

Emotional wellbeingAt the end of one month from baseline visit

Assessed by the Perceived Stress Scale on a 5-point Likert-type scale, ranging from 0 (never) to 4 (very often). A higher score indicates a higher perceived stress level.

Proportion of participants with optimal blood glucose controlAt the end of one month from baseline visit

Based on recommended pre-meal range of 4.4-5.5 mmol/L and 2h post-meal range of 5.5-6.6 mmol/L

Trial Locations

Locations (1)

KK Women's and Children's Hospital

πŸ‡ΈπŸ‡¬

Singapore, Singapore

Β© Copyright 2025. All Rights Reserved by MedPath